Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Option for Additional Financing of Up to $50 Million

Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Option for Additional Financing of Up to $50 Million Source link